S100A4 and hepatocellular carcinoma: In addition, ectopic overexpression of S100A4 led to upregulation of oncogenic microRNA (miR)-155 expression in hepatocellular carcinoma cells, and an miR-155 inhibitor significantly attenuated the invasion-promoting effects of S100A4 [32].